First Time Loading...

bluebird bio Inc
NASDAQ:BLUE

Watchlist Manager
bluebird bio Inc Logo
bluebird bio Inc
NASDAQ:BLUE
Watchlist
Price: 0.9145 USD -3.48% Market Closed
Updated: Jun 7, 2024

bluebird bio Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

bluebird bio Inc
Other Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
bluebird bio Inc
NASDAQ:BLUE
Other Current Assets
$28.8m
CAGR 3-Years
-20%
CAGR 5-Years
-1%
CAGR 10-Years
20%
Abbvie Inc
NYSE:ABBV
Other Current Assets
$4.6B
CAGR 3-Years
5%
CAGR 5-Years
21%
CAGR 10-Years
6%
Gilead Sciences Inc
NASDAQ:GILD
Other Current Assets
$2.8B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Other Current Assets
$2.8B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Assets
$511.1m
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Assets
$414.9m
CAGR 3-Years
25%
CAGR 5-Years
18%
CAGR 10-Years
17%

See Also

What is bluebird bio Inc's Other Current Assets?
Other Current Assets
28.8m USD

Based on the financial report for Sep 30, 2023, bluebird bio Inc's Other Current Assets amounts to 28.8m USD.

What is bluebird bio Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
20%

Over the last year, the Other Current Assets growth was 38%. The average annual Other Current Assets growth rates for bluebird bio Inc have been -20% over the past three years , -1% over the past five years , and 20% over the past ten years .